ARTES Biosciences and Basic Pharma are interested and proud to offer the first commercial samples of our joint recombinant human serum albumin (rHSA) production from yeast (Hansenula polymorpha) for research and development purposes. During BIO-Europe our partner ARTES Biosciences will be available at booth 149 to provide comprehensive insights and technical background on our rHSA. Including a sample for testing purposes.
BIO-Europe, Europe’s leading partnering event, provides an exceptional opportunity to connect with more potential partners in just three days than you could throughout the entire year. Overall, it enables you to connect with delegates spanning the global life science ecosystem to propel dealmaking and innovation.
rHSA made with ARTES´ Hansenula , developed and manufactured in collaboration between ARTES and BasicPharma Biotech. rHSA has a wide range of applications ranging from stablizer in cell formulation solutions, coating of medical devices, and as blocking agent. The use of recombinant sources provides a.o. great benefits like batch consistency, purity, and non-toxic side effects. With rHSA we are focused on the future!
